Biogen Pharmachem Industries Limited (BOM:531752)
India flag India · Delayed Price · Currency is INR
0.2900
+0.0100 (3.57%)
At close: Nov 17, 2026

BOM:531752 Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
12.4819.5911.987.892.524.81
Revenue Growth
-63.05%63.57%51.78%215.26%-89.91%52.90%
Gross Profit
12.4819.5911.987.892.54.66
Operating Income
-0.173.580.893.38-1.963.04
Net Income
4.858.6-2.9319.314.56-0.09
Earnings Per Share
-0.01-0.000.030.01-0.00
EPS Growth
---323.91%--

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
0.133.2220.160.171.290.83
Total Debt
------
Net Cash (Debt)
0.133.2220.160.171.290.83
Net Cash Growth
-96.52%-84.05%11830.77%-86.87%54.69%-
Net Cash Per Share
-0.000.030.000.000.00

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
7.9415.68-10.8219.4517.0413.98
Free Cash Flow
7.9415.68-10.8219.4517.0413.98
Free Cash Flow Growth
-40.64%--14.09%21.89%-64.60%

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
100.00%100.00%100.00%100.00%100.00%18.79%
Operating Margin
-1.34%18.26%7.46%42.87%-78.19%12.24%
Pretax Margin
46.65%48.84%-22.53%244.67%186.50%-0.35%
Profit Margin
38.86%43.87%-24.44%244.67%181.98%-0.35%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
52.1238.72-35.8384.53-
PS Ratio
20.2516.9952.3187.67153.8336.83